News
ATRI
399.83
-0.63%
-2.52
Weekly Report: what happened at ATRI last week (0415-0419)?
Weekly Report · 1d ago
Positive Signs As Multiple Insiders Buy Atrion Stock
Atrion Corporation's (NASDAQ:ATRI) insider trading is good news for shareholders. In the last year Atrion insiders bought US$105k worth of shares at a price of US$409. The company has had no insider transactions in the last three months. At rion insiders own 16% of the company. It's a good sign to see an insider buy up shares at higher prices. But we warn you to be aware of the risks associated with atrion. You can see the insider transactions of Atrions over the last 12 months.
Simply Wall St · 5d ago
Weekly Report: what happened at ATRI last week (0408-0412)?
Weekly Report · 04/15 09:26
Weekly Report: what happened at ATRI last week (0401-0405)?
Weekly Report · 04/08 09:28
Weekly Report: what happened at ATRI last week (0325-0329)?
Weekly Report · 04/01 09:28
Weekly Report: what happened at ATRI last week (0318-0322)?
Weekly Report · 03/25 09:28
Dividend Champion, Contender, And Challenger Highlights: Week Of March 24
Home Dividends Analysis Dividend Quick Picks: Week of March 24. Justin Law's weekly summary of dividend activity for D dividend Champions, Contenders, and Challengers. This week, he highlights recent and upcoming dividend related activity for dividend stocks on the D dividend champions list.
Seeking Alpha · 03/24 12:37
Atrion Corporation Is Overvalued For The Direction Fundamentals Are Heading
Atrion Corporation is a healthcare company focused on fluid delivery products. The company has experienced a decline in revenue, profits, and cash flows. The stock is currently expensive compared to similar companies. Despite the potential for improvement in the future, the company is overvalued. Atrion has been downgraded to a 'sell' rating.
Seeking Alpha · 03/24 12:34
Subdued Growth No Barrier To Atrion Corporation (NASDAQ:ATRI) With Shares Advancing 25%
Atrion Corporation (NASDAQ:ATRI) has posted a 25% gain in the last month. The company's share price is still down 34% over the last year. Atrion has a 38.6x price-to-earnings ratio and is trading at a much higher than average P/E ratio. Its recent earnings have been in decline over the medium-term, and the company is expected to perform better than the market.
Simply Wall St · 03/23 12:11
Weekly Report: what happened at ATRI last week (0304-0308)?
Weekly Report · 03/11 09:27
Weekly Report: what happened at ATRI last week (0226-0301)?
Weekly Report · 03/04 09:28
Atrion Non-GAAP EPS of $3.65, revenue of $43.6M
Seeking Alpha · 02/29 23:06
Atrion Q4 EPS $3.65 Down From $4.70 YoY, Sales $43.58M Up From $42.85M YoY
Atrion reported quarterly earnings of $3.65 per share. This is a 22.34 percent decrease over the same period last year. The company reported $43.58 million in sales for the third quarter of 2013. The company also reported a 1.70 percent increase in sales from the previous quarter.
Benzinga · 02/29 21:14
BRIEF-Atrion Q4 EPS USD 3.65
Reuters · 02/29 21:00
*Atrion 4Q EPS $3.65 >ATRI
Dow Jones · 02/29 21:00
Atrion: Q4 Earnings Snapshot
Atrion Corp. Reports fourth-quarter earnings of $6.4 million. The medical device maker posted revenue of $43.6 million in the period. For the year, the company reported profit of $19.5 million. Atrion shares have decreased 4% since the beginning of the year.
Barchart · 02/29 15:17
Atrion declares $2.20 dividend
Dividend Stocks News Atrion declares $2.20 dividend Feb. 27, 2024 3:11 PM ETAtrion Corporation (ATRI) Stock. Forward yield 2.45% Payable March 29; for shareholders of record March 15; ex-div March 14.
Seeking Alpha · 02/27 20:11
Press Release: Atrion Corporation Declares Quarterly Cash Dividend
Atrion Corporation develops and manufactures products primarily for medical applications. The dividend will be payable on March 29, 2024 to stockholders of record on March 15, 2024. Atrion Corporation declared a quarterly dividend of $2.20 per share on its outstanding shares of Common Stock.
Dow Jones · 02/27 18:20
Atrion Corporation Declares Quarterly Cash Dividend
Atrion Corporation declares a quarterly dividend of $2.20 per share on its outstanding shares of Common Stock. The dividend will be payable on March 29, 2024 to stockholders of record on March 15, 2024. Atrion's Board of Directors declared the dividend.
Barchart · 02/27 12:20
Weekly Report: what happened at ATRI last week (0219-0223)?
Weekly Report · 02/26 09:30
More
Webull provides a variety of real-time ATRI stock news. You can receive the latest news about Atrion Corp through multiple platforms. This information may help you make smarter investment decisions.
About ATRI
Atrion Corporation develops and manufactures products, primarily for medical applications. The Company's medical products are used in a number of fields including fluid delivery, cardiovascular, and ophthalmic applications. It has developed a variety of proprietary valves designed to precisely fill, hold, and release and/or remove controlled amounts of fluids, including blood and drugs, or gasses on demand for use in areas such as intubation, intravenous, catheter, and other applications in fields including anesthesia and oncology. The core of its cardiovascular products is its Myocardial Protection System, a technology that is the only open-heart surgery system that delivers to the heart essential fluids and medications, mixes critical drugs, and controls temperature, pressure, and other important variables. The Company also manufactures a line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults.